2022 annual financial data
Zevra Therapeutics 2022 Operating margin
Direct answer
Operating margin was -418.91%.
Operating income was -42,565,000 USD and net income was -26,772,000 USD.
Operating cash flow was -18,717,000 USD.
Get free Zevra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,161,000 USD
- Operating income
- -42,565,000 USD
- Net income
- -26,772,000 USD
- Operating cash flow
- -18,717,000 USD